NYU Langone Health
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, NYU Langone Health sits in the top decile of US sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count).
NYU Langone Health: 1,164 sponsored US clinical trials, 197 recruiting.
NYU Langone Health sponsors 1,164 registered US clinical trials on ClinicalTrials.gov, 197 of them currently recruiting, and 741 completed. 123 of these trials are in Phase 3-4 (later-stage) and 231 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 12 trials.
Top-decile sponsor footprint
NYU Langone Health ranks in the top decile of sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
741 of 866 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,164 total, page 7 of 24
Fatigue Reduction in Chronic Kidney Disease (CKD)
NCT06768983
Using Generative Artificial Intelligence (AI) to Create Patient-Friendly Discharge Summaries
NCT06711458
Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized Patients
NCT06222554
Efficacy Of Combined Nebulized Hypertonic Saline and Chest Percussion Therapy in Acute Viral Bronchiolitis
NCT06441162
Geniculate Artery Embolization for Treatment of Persistent Knee Pain Post Total Knee Arthroplasty
NCT06134817
Text Messaging to Improve Adherence To Repeat Colonoscopy In a Veterans Affairs (VA) Hospital
NCT06185374
Optimizing Music-Based Interventions for Stroke
NCT06215703
ATTENUATE (rAdpad proTecTion drapE iN redUcing rAdiaTion Exposure) Trial
NCT06233578
Exoskeletal Support in Stroke
NCT05996198
Study of the Aliviado DSD Caregiving Mastery Program
NCT05630014
NYU Langone Health Headache Center Learning Migraine Self-Management Techniques Study
NCT06077812
Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening
NCT06000501
Pro-rEsolving and pRo-inflammatory reSPonses to Acute exhaustIve exeRcisE in Healthy Individuals
NCT05923125
Stroke and Anxiety Reduction
NCT06013982
Time Restricted Eating for Weight Loss Maintenance
NCT05742165
Aromatherapy and Anxiety Study
NCT05832983
Impact of Visual Arts Immersion
NCT05877976
Does Weightbearing Crutch Technology Impact Patient Compliance?
NCT05825079
Daratumumab in STK11 Mutated NSCLC
NCT05807048
UB-312 in Patients With Synucleinopathies
NCT05634876
Phthalate and Bisphenol Exposure During Minipuberty
NCT05864209
Aromatherapy and Happiness
NCT05864222
Integrating Cultural Aspects Into Diabetes Education
NCT05492916
Impact of Online Ordering on Low-Income Adults' Food Security in Online Food Pantry Settings
NCT05752721
Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia
NCT05643196
Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp Configurations
NCT05686421
Clinician Decision Making Regarding Surveillance for Low-risk Intraductal Papillary Mucinous Neoplasms of The Pancreas
NCT06311032
Flatbush FHC Proactive Colorectal Cancer Screening and Navigation
NCT05646355
Using Online Food Retail "Nudges" to Promote Healthier Beverage Intake Among Low-Income Children
NCT06222541
Efficacy of STABL Virtual Rehabilitation
NCT05556850
Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders
NCT05718583
Level of Physical Activity and Fear Learning
NCT05203731
Cannabidiol as a Treatment for Social Anxiety Disorder (R61)
NCT05571592
Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC
NCT05691829
Assessing the Effects of Patient Self-Rating of Voice Quality on Voice Therapy Attendance and Outcomes
NCT05237648
At-Home Gait Assessment
NCT05724901
Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA)
NCT05615922
Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer
NCT05483075
The Retrain Your Brain for Healthy Eating Study
NCT05203718
Brachial Right Ventricle - Endomyocardial Biopsy
NCT05289180
Addressing Antihypertensive Medication Adherence Through EHR-enabled Teamlets in Primary Care
NCT05349422
Community-engaged Hypertension Prevention Program in Black Men
NCT05447962
Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure
NCT04609683
A Teleheath tDCS Approach to Decrease Cannabis Use
NCT05005013
Enteral Feeding and Splanchnic NIRS Values in Infants With Neonatal Encephalopathy (NE)
NCT05471336
Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer
NCT05318131
Cleaner Air for Better Cardiac Biomarkers
NCT05379400
Wearable Sensors and Artificial Intelligence for Carbohydrate Counting
NCT05335889
Lower Tourniquet Pressure Study
NCT04994405
Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following ACL Reconstruction With Bone Patellar Tendon Bone Autograft:
NCT05286307
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 99 |
| Phase 2 | 132 |
| Phase 3 | 28 |
| Phase 4 | 95 |
Therapeutic Areas
What is open in the NYU Langone Health pipeline
197 recruiting of 1,164 indexed (17% open); 741 completed (64%).
Phase mix: 123 late (III/IV) vs 231 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
NYU Langone Health: open-pipeline peers nationwide
Peers matched on 1,164 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
NYU Langone Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,164 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 17% open enrollment (± trial volume)
- CSL Behring · 17% recruiting · 71 trials
- Penn State University · 17% recruiting · 219 trials
- University of Hawaii · 17% recruiting · 77 trials
- University of Utah · 17% recruiting · 818 trials
Related
What to do with this NYU Langone Health page
1,164 registered trials is a research-attention snapshot, not an endorsement of NYU Langone Health or any single study.
- 197 of NYU Langone Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition NYU Langone Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
NYU Langone Health pipeline card: 1,164 registered trials from official public datasets.Report a data error.